These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 21568628

  • 1. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
    Riedel M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Schennach-Wolff R.
    World J Biol Psychiatry; 2012 Jan; 13(1):30-8. PubMed ID: 21568628
    [Abstract] [Full Text] [Related]

  • 2. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 3. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I, Ravanić D, Popović V, Vladejić S, Stanojević A, Stojanović M.
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [Abstract] [Full Text] [Related]

  • 4. Akathisia and suicidal ideation in first-episode schizophrenia.
    Seemüller F, Schennach R, Mayr A, Musil R, Jäger M, Maier W, Klingenberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Schlösser R, Schneider F, Ohmann C, Lewitzka U, Gaebel W, Möller HJ, Riedel M, German Study Group on First-Episode Schizophrenia.
    J Clin Psychopharmacol; 2012 Oct; 32(5):694-8. PubMed ID: 22926606
    [Abstract] [Full Text] [Related]

  • 5. Outcome of suicidal patients with schizophrenia: results from a naturalistic study.
    Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M.
    Acta Psychiatr Scand; 2010 May; 121(5):359-70. PubMed ID: 19878135
    [Abstract] [Full Text] [Related]

  • 6. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W.
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
    [Abstract] [Full Text] [Related]

  • 7. The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone.
    Seemüller F, Lewitzka U, Bauer M, Meyer S, Musil R, Schennach R, Riedel M, Doucette S, Möller HJ.
    Pharmacopsychiatry; 2012 Nov; 45(7):292-6. PubMed ID: 22614116
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM, Nepal MK, Koirala NR, Sharma VD, Gurung CK, Adhikari SR.
    Kathmandu Univ Med J (KUMJ); 2006 Nov; 4(2):152-60. PubMed ID: 18603890
    [Abstract] [Full Text] [Related]

  • 10. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1504-9. PubMed ID: 17692448
    [Abstract] [Full Text] [Related]

  • 11. Testosterone in first-episode schizophrenia.
    Cesková E, Prikryl R, Kaspárek T.
    Neuro Endocrinol Lett; 2007 Dec 01; 28(6):811-4. PubMed ID: 18063925
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
    Kane JM, Potkin SG, Daniel DG, Buckley PF.
    J Clin Psychiatry; 2011 Feb 01; 72(2):194-204. PubMed ID: 20673553
    [Abstract] [Full Text] [Related]

  • 13. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients.
    Lee SM, Chou YH, Li MH, Wan FJ, Yen MH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1101-7. PubMed ID: 17475386
    [Abstract] [Full Text] [Related]

  • 14. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD, Rabinowitz J, Eerdekens M, Davidson M.
    Am J Psychiatry; 2005 Oct 30; 162(10):1888-95. PubMed ID: 16199835
    [Abstract] [Full Text] [Related]

  • 15. A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.
    Stahl SM, Malla A, Newcomer JW, Potkin SG, Weiden PJ, Harvey PD, Loebel A, Watsky E, Siu CO, Romano S.
    J Clin Psychopharmacol; 2010 Aug 30; 30(4):425-30. PubMed ID: 20571437
    [Abstract] [Full Text] [Related]

  • 16. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
    Salimi S, Fotouhi A, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Mohammadi MR, Noorbala AA, Ahmadi-Abhari SA, Hajiazim M, Abbasi SH, Akhondzadeh S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):726-32. PubMed ID: 18096287
    [Abstract] [Full Text] [Related]

  • 17. Trajectories and antecedents of treatment response over time in early-episode psychosis.
    Levine SZ, Rabinowitz J.
    Schizophr Bull; 2010 May 01; 36(3):624-32. PubMed ID: 18849294
    [Abstract] [Full Text] [Related]

  • 18. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.
    J Clin Psychopharmacol; 1993 Feb 01; 13(1):25-40. PubMed ID: 7683702
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.
    Himei A, Okamura T.
    Psychiatry Clin Neurosci; 2005 Oct 01; 59(5):556-62. PubMed ID: 16194258
    [Abstract] [Full Text] [Related]

  • 20. Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.
    Emsley R, Rabinowitz J, Medori R, Early Psychosis Global Working Group.
    Schizophr Res; 2007 Jan 01; 89(1-3):129-39. PubMed ID: 17095194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.